The Personalized OncoGenomics (POG) Program would not be possible without the support of our funders and collaborating partners. POG is pleased to announce that it is a member of the International Cancer Genome Consortium — Accelerating Research in Genomic Oncology (ICGC-ARGO).
We gratefully acknowledge all funders and supporting partners of the BC Cancer Genome Sciences Center and the development of the Personalized OncoGenomics Program.
This work would not be possible without the generous support of the following organizations: BC Cancer Foundation, Genome British Columbia, Genome Canada, Canada Foundation for Innovation, BC Knowledge Development Fund (Government of British Columbia), The Cancer Genome Atlas (TCGA) Program (National Cancer Institute (NCI), National Human Genome Research Institute (NHGRI)), The Genotype-Tissue Expression (GTEx) Project (National Institutes of Health (NIH))
Thank you to the following organizations who support our work: Centre for Clinical Genomics (CCG), International Cancer Genome Consortium — Accelerating Research in Genomic Oncology (ICGC-ARGO), BC Cancer Hereditary Cancer Program (HCP), Enhanced Pancreatic Cancer Profiling for Individualized Care (EPPIC) (Terry Fox Translational Research Program), Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis (PanGen) (BC Cancer, Terry Fox Research Institute (TFRI), Pancreas Centre BC), PRecision Oncology For Young peopLE (PROFYLE) (Terry Fox Research Institute (TFRI)), Terry Fox Designated Canadian Comprehensive Cancer Centres Network (TF4CN) (Princess Margaret Cancer Centre, Terry Fox Research Institute (TFRI), BC Cancer), Canadian Distributed Infrastructure for Genomics (CanDIG), Treehouse Childhood Cancer Initiative, Gilead Sciences.